Clinical Trial Search

Primary: Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI) — 7; 6 Participants

Primary: The Primary Efficacy Outcome of the Study is Response to Treatment Which Will be Assessed at the End of Therapy. Successful Response to Treatment is Defined as…

Primary: Rate of Catheter-associated Urinary Tract Infection — 10; 12 infections per 1000 days

Primary: Clinical Response Within 48 Hours — 28 Participants

Primary: Number of Central Venous Catheter Hubs With Internal Contamination — 42; 18; 39; 14 contaminated hubs

Primary: Urinary Tract Infection Rate — 24; 29 Participants — p=0.30

Primary: Number of Participants With Appropriate Treatment — 31; 23 Participants — p=0.45

Primary: Occurrence of Symptomatic Urinary Tract Infections (UTIs) — 19; 20; 2; 0 participants — p=0.0383

Primary: Rate of UTI While Colonized With E. Coli 83972. — 8.5 UTIs per 1000 patient-days

Primary: Disinfecting Barrier Cap Compliance — 98.43 percentage of connector with compliance

Primary: Total Bacteria Count Change From Baseline and After 24 Hours. — -62519; 57448 CFU/mL — p=0.6250

Primary: Number of Subjects With Shunt Infections — 14 participants

Primary: Infections Per 1,000 (CAUTI) Days — 0.8429 infection per 1,000 catheter days

Primary: The Number of Catheter Related Bloodstream Infections (BSI) /1000 Catheter Days in Both Arms — 4.74; 4.72 BSIs /1000 catheter days — p=0.05

Primary: Upper Extremity CR-UEVT — 7; 11 Participants

Primary: Bacteraemia Rate — 2; 1 episodes — p=1.00

Primary: Total Number of MDRO (Multidrug Resistant Organisms) Isolated — 1299; 1732 Total Number of MDRO isolates — p=<0.05

Primary: Participants With Clinically-diagnosed and Treated UTI's. — 15; 30 participants

Primary: Number of Patients With a Major Cardiac Implantable Electronic Devices (CIED) Infection — 5; 6 Participants

Primary: Rate of PICC Line Occlusions — 37 percentage of enrolled subjects

Primary: Catheter-associated Venous Thrombosis — 3; 3 Participants

Primary: Positive Blood Cultures (PBC's) Per 1,000 Central Venous Catheter (CVC)-Days — 0.28; 0.75 PBCs per 1,000 CVC-days

Primary: Participants With Complications With Central Access Including Insertion — 14; 10 Participants — p=0.271

Primary: Number of Infections — 4; 5; 4; 5 Infections

Primary: Urinary Tract Infection — 11; 12 UTI

Primary: Number of Patients Who Developed Postoperative Urinary Retention (POUR), Unable to Void a Volume Greater Than or Equal to 30ml/hr — 4; 5 Participants

Primary: Blood Flow Rate at First Use After Insertion — 277; 383 mL/min

Primary: Urinary Tract Infection After Percutaneous Nephrostomy Procedure — 5; 10 Percutaneous nephrostomy procedure — p=0.548

Primary: To Evaluate the Effect of Oral Supplementation With Lactobacillus Reuteri on the Frequency of Confirmed UTI in Adult Women With Recurrent UTI. — 1.2; 1.3 Number of…

Primary: Local Catheter Site Infection (LCSI) — 50; 70 Events — p=0.082